Healthcare Market Research Reports & Industry Analysis

Publications found: 73,128
Sort by:

Iron Overload Disorder - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Iron Overload Disorder' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report – ... profile and probable launch date estimation Market Outlook & Market Forecast Historic, current and forecasted market trend (High, Base case, Low) of the ...

December 2017 138 pages

Ischemic Stroke - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Ischemic Stroke' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ... emerging biomarkers, pipeline assessment, competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement ...

December 2017 212 pages

Juvenile Rheumatoid Arthritis - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Juvenile Rheumatoid Arthritis' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report – ... profile and probable launch date estimation Market Outlook & Market Forecast Historic, current and forecasted market trend (High, Base case, Low) of ...

December 2017 177 pages

Kaposi'S Sarcoma - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Kaposi's Sarcoma' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ... emerging biomarkers, pipeline assessment, competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement ...

December 2017 165 pages

Klebsiella Pneumoniae Infections - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Klebsiella Pneumoniae Infections' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report ... profile and probable launch date estimation Market Outlook & Market Forecast Historic, current and forecasted market trend (High, Base case, Low) of ...

December 2017 176 pages

Left Ventricular Dysfunction - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Left Ventricular Dysfunction' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report – ... profile and probable launch date estimation Market Outlook & Market Forecast Historic, current and forecasted market trend (High, Base case, Low) of ...

December 2017 196 pages

Leishmaniasis - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Leishmaniasis' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report ... , competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement scenario; Public, Private, Medicare, ...

December 2017 200 pages

Liposarcoma - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Liposarcoma' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report ... , competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement scenario; Public, Private, Medicare, ...

December 2017 203 pages

Liver Failure - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Liver Failure' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ... emerging biomarkers, pipeline assessment, competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement ...

December 2017 200 pages

Lupus Nephritis - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Lupus Nephritis' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ... emerging biomarkers, pipeline assessment, competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement ...

December 2017 215 pages

Male Hypogonadism - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Male Hypogonadism' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ... emerging biomarkers, pipeline assessment, competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement ...

December 2017 168 pages

Malignant Glioma - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Malignant Glioma' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ... emerging biomarkers, pipeline assessment, competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement ...

December 2017 171 pages

Malignant Mesothelioma - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Malignant Mesothelioma' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ... biomarkers, pipeline assessment, competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement ...

December 2017 198 pages

Medullary Thyroid Cancer - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Medullary Thyroid Cancer ' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report – ... profile and probable launch date estimation Market Outlook & Market Forecast Historic, current and forecasted market trend (High, Base case, Low) of the ...

December 2017 173 pages

Medulloblastoma - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Medulloblastoma' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report ... , competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement scenario; Public, Private, Medicare, ...

December 2017 172 pages

Metastatic Hepatocellular Carcinoma - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Metastatic Hepatocellular Carcinoma' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report ... profile and probable launch date estimation Market Outlook & Market Forecast Historic, current and forecasted market trend (High, Base case, Low) ...

December 2017 192 pages

Metastatic Hormone Refractory Prostate Cancer - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Metastatic Hormone Refractory Prostate Cancer' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology ... Myers Squibb, Cellcentric Ltd., Pfizer, Astellas Pharma Inc, Astrazeneca, Prostate Cancer Uk, Pfizer, Dextech Medical Ab, Immunomedics, Inc., Suzhou Kintor ...

December 2017 173 pages

Metastatic Prostate Cancer - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Metastatic Prostate Cancer' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report ... Myers Squibb, Cellcentric Ltd., Pfizer, Astellas Pharma Inc, Astrazeneca, Prostate Cancer Uk, Pfizer, Dextech Medical Ab, Immunomedics, Inc., Suzhou Kintor ...

December 2017 152 pages

Metastatic Renal Cell Carcinoma (Mrcc) - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Metastatic Renal Cell Carcinoma (mRCC) ' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ...

December 2017 164 pages

Moderate Psoriasis - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Moderate Psoriasis' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ... emerging biomarkers, pipeline assessment, competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement ...

December 2017 148 pages

Myasthenia Gravis - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Myasthenia Gravis' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ... emerging biomarkers, pipeline assessment, competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement ...

December 2017 203 pages

Mycosis Fungoides - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Mycosis Fungoides' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ... emerging biomarkers, pipeline assessment, competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement ...

December 2017 209 pages

Myelofibrosis - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Myelofibrosis' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report ... , competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement scenario; Public, Private, Medicare, ...

December 2017 200 pages

Myopia - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Myopia' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report ... , competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement scenario; Public, Private, Medicare, ...

December 2017 156 pages

Nasopharyngeal Cancer - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Nasopharyngeal Cancer' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ... biomarkers, pipeline assessment, competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement ...

December 2017 170 pages

Neuroblastoma - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Neuroblastoma' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report ... , competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement scenario; Public, Private, Medicare, ...

December 2017 217 pages

Nicotine Addiction - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Nicotine Addiction' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ... emerging biomarkers, pipeline assessment, competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement ...

December 2017 186 pages

Nocturia - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Nocturia' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast Report ... , competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement scenario; Public, Private, Medicare, ...

December 2017 218 pages

Non-Small Cell Lung Cancer (Nsclc) - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Non-Small Cell Lung Cancer (NSCLC)' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and ... specific treatment and disease management for the patients with Non-Small Cell Lung Cancer (NSCLC) in the US, Europe, Japan, and China. Future treatment paradigm ...

December 2017 172 pages

Nosocomial Infections - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Nosocomial Infections' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ... biomarkers, pipeline assessment, competitive landscape, KOLs perspective, Market access - Country Specific Regulatory scenario s, Patent landscape, reimbursement ...

December 2017 211 pages

Lung Net (L Net) - Market Access, Reimbursement Outlook, Competitive Landscape, Epidemiology and Forecast Report - 2015 To 2030

US$ 6,550.00

Thelansis Knowledge Partners 'Neuroendocrine Tumor(NET)' - Market Access, Reimbursement Outlook, Competitive Landscapet, Epidemiology and Forecast ...

December 2017 216 pages

Asia-Pacific Tuberculin Market by Manufacturers, Regions, Type and Application, Forecast to 2022

US$ 4,480.00

... the Asia-Pacific Tuberculin market. Chapter 1, to describe Tuberculin Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force; Chapter 2, to analyze the manufacturers of Tuberculin ...

December 2017 123 pages

Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Targeted RNA Sequencing Market 2017 Forecast to 2022

US$ 4,880.00

... focuses on the Targeted RNA Sequencing in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report ... GENEWIZ Market Segment by Regions, regional analysis covers North America (USA, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) ...

December 2017 115 pages

Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Remanufactured Medical Imaging Device Market 2017 Forecast to 2022

US$ 4,880.00

... the Remanufactured Medical Imaging Device in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This ... Technology Market Segment by Regions, regional analysis covers North America (USA, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) ...

December 2017 122 pages

Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Probiotics Gummies Market 2017 Forecast to 2022

US$ 4,880.00

... report focuses on the Probiotics Gummies in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report ... Sundown Market Segment by Regions, regional analysis covers North America (USA, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) ...

December 2017 121 pages

Asia-Pacific Patient Engagement Solutions Market by Manufacturers, Regions, Type and Application, Forecast to 2022

US$ 4,480.00

... to deeply display the Asia-Pacific Patient Engagement Solutions market. Chapter 1, to describe Patient Engagement Solutions Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force; Chapter ...

December 2017 123 pages

Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Pain Management Drugs Market 2017 Forecast to 2022

US$ 4,880.00

... focuses on the Pain Management Drugs in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report ... Purdue Market Segment by Regions, regional analysis covers North America (USA, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia ...

December 2017 120 pages

Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Medical Guide Wire Market 2017 Forecast to 2022

US$ 4,880.00

... focuses on the Medical Guide Wire in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report ... Yixinda Market Segment by Regions, regional analysis covers North America (USA, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) Asia ...

December 2017 124 pages

Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Chemotherapy Devices Market 2017 Forecast to 2022

US$ 4,880.00

... report focuses on the Chemotherapy Devices in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report ... Medical Market Segment by Regions, regional analysis covers North America (USA, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) ...

December 2017 122 pages

Asia-Pacific Calcium Tablets Market by Manufacturers, Regions, Type and Application, Forecast to 2022

US$ 4,480.00

... Asia-Pacific Calcium Tablets market. Chapter 1, to describe Calcium Tablets Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force; Chapter 2, to analyze the manufacturers of Calcium Tablets ...

December 2017 117 pages

Global (North America, Europe and Asia-Pacific, South America, Middle East and Africa) Agrigenomics Market 2017 Forecast to 2022

US$ 4,880.00

... This report focuses on the Agrigenomics in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report ... SciGenom Market Segment by Regions, regional analysis covers North America (USA, Canada and Mexico) Europe (Germany, France, UK, Russia and Italy) ...

December 2017 120 pages

E3 Ubiquitin Protein Ligase Mdm2 (Double Minute 2 Protein or Hdm2 or Oncoprotein Mdm2 or p53 Binding Protein Mdm2 or MDM2 or EC 6.3.2.) - Pipeline Review, H2 2017

US$ 3,500.00

... by identifying key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding E3 Ubiquitin Protein Ligase Mdm2 (Double Minute 2 Protein or Hdm2 or Oncoprotein Mdm2 or p53 Binding Protein Mdm2 or MDM2 or EC 6.3.2.) development landscape Develop and ...

December 2017 75 pages

Leucine Rich Repeat Serine/Threonine Protein Kinase 2 (Dardarin or LRRK2 or EC 2.7.11.1) - Pipeline Review, H2 2017

US$ 3,500.00

... Leucine Rich Repeat Serine/Threonine Protein Kinase 2 (Dardarin or LRRK2 or EC 2.7.11.1) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources The report covers pipeline products ...

December 2017 48 pages

Prostate Specific Antigen (Gamma Seminoprotein or Kallikrein 3 or P 30 Antigen or Semenogelase or KLK3 or EC 3.4.21.77) - Pipeline Review, H2 2017

US$ 3,500.00

... by identifying key players and it’s most promising pipeline therapeutics Devise corrective measures for pipeline projects by understanding Prostate Specific Antigen (Gamma Seminoprotein or Kallikrein 3 or P 30 Antigen or Semenogelase or KLK3 or EC 3.4.21.77) development landscape Develop and design ...

December 2017 63 pages

Smoking Addiction - Pipeline Review, H2 2017

US$ 2,000.00

... . The Smoking Addiction (Central Nervous System) pipeline guide also reviews of key players involved in therapeutic development for Smoking Addiction and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

December 2017 89 pages

Vasomotor Symptoms of Menopause (Hot Flashes) - Pipeline Review, H2 2017

US$ 2,000.00

... . The Vasomotor Symptoms of Menopause (Hot Flashes) (Women's Health) pipeline guide also reviews of key players involved in therapeutic development for Vasomotor Symptoms of Menopause (Hot Flashes) and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies ...

December 2017 57 pages

China Collagenase Market by Manufacturers, Regions (Province), Type and Application, Forecast to 2022

US$ 4,480.00

... China Collagenase market. Chapter 1, to describe Collagenase Introduction, product type and application, market overview, market analysis by Region (province), market opportunities, market risk, market driving force; Chapter 2, to analyze the manufacturers of Collagenase ...

December 2017 123 pages

China Cetirizine Hydrochloride Market by Manufacturers, Regions (Province), Type and Application, Forecast to 2022

US$ 4,480.00

... display the China Cetirizine Hydrochloride market. Chapter 1, to describe Cetirizine Hydrochloride Introduction, product type and application, market overview, market analysis by Region (province), market opportunities, market risk, market driving force; Chapter ...

December 2017 116 pages

China BCG Vaccine Market by Manufacturers, Regions (Province), Type and Application, Forecast to 2022

US$ 4,480.00

... display the China BCG Vaccine market. Chapter 1, to describe BCG Vaccine Introduction, product type and application, market overview, market analysis by Region (province), market opportunities, market risk, market driving force; Chapter ...

December 2017 116 pages

China Bacterial Vaginosis Drug Market by Manufacturers, Regions (Province), Type and Application, Forecast to 2022

US$ 4,480.00

... display the China Bacterial Vaginosis Drug market. Chapter 1, to describe Bacterial Vaginosis Drug Introduction, product type and application, market overview, market analysis by Region (province), market opportunities, market risk, market driving force; Chapter ...

December 2017 117 pages

Filters

Search

Categories

1,254
193
212
1,214
34
241
217
160
142
64,306
1,332
1,265
2,373
185

Publishers

649
541
179
32
1
1,509
34
239
366
389
103
148
348
3
202
3
6
1,623
487
80
123
208
112
31
1,049
383
23
40
68
513
953
34
29,954
248
501
3,036
1
1
2
3
16
536
361
1
1,357
1,806
60
1,696
8
7,373
2,206
6,530
321
66
3
36
200
29
29
143
42
83
3
281
85
20
6
43
14
1
178
48
359
36
44
10
11
18
168
385
8
3
18
58
913
6
89
12
24
15
1,286
229
128
386
3
74
10
119
227
46
474
26
133
4

Regions

201
97
86
75
74
50
48
42
41
40
36
36
35
31
30
29
28
27
27
26
24
24
18
17
17
17
17
16
16
15
13
12
12
11
10
9
8
8
8
7
7
6
6
6
6
5
4
4
4
4
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
3
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
798
552
2
2
2
118
198
104
61
38
709
75
136
531
215
1,137
66,824

Price

—

Date

—

Pages

—

Offers

1
280
1
1